What is the equity of Betta Pharmaceuticals Co this year?
Betta Pharmaceuticals Co has equity of 5.25 B CNY this year.
Betta Pharmaceuticals Co Equity 2024
Betta Pharmaceuticals Co Equity
5.25 B CNY
Ticker
300558.SZ
ISIN
CNE100002DD9
In 2024, Betta Pharmaceuticals Co's equity was 5.25 B CNY, a 8.29% increase from the 4.85 B CNY equity in the previous year.
Betta Pharmaceuticals Co Aktienanalyse
What does Betta Pharmaceuticals Co do?
Betta Pharmaceuticals Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Betta Pharmaceuticals Co's Equity
Betta Pharmaceuticals Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Betta Pharmaceuticals Co's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Betta Pharmaceuticals Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Betta Pharmaceuticals Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Betta Pharmaceuticals Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Betta Pharmaceuticals Co stock
What was the equity of Betta Pharmaceuticals Co compared to the previous year?
The equity of Betta Pharmaceuticals Co has increased/decreased by 8.29% increased compared to the previous year.
What impact does a high equity have on investors of Betta Pharmaceuticals Co?
A high equity is advantageous for investors of Betta Pharmaceuticals Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Betta Pharmaceuticals Co?
A low equity can be a risk for investors of Betta Pharmaceuticals Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Betta Pharmaceuticals Co affect the company?
An increase in equity of Betta Pharmaceuticals Co can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Betta Pharmaceuticals Co affect the company?
A reduction in equity of Betta Pharmaceuticals Co can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Betta Pharmaceuticals Co?
Some factors that can affect the equity of Betta Pharmaceuticals Co include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Betta Pharmaceuticals Co so important for investors?
The equity of Betta Pharmaceuticals Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Betta Pharmaceuticals Co take to change the equity?
To change equity, Betta Pharmaceuticals Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Betta Pharmaceuticals Co pay?
Over the past 12 months, Betta Pharmaceuticals Co paid a dividend of 0.07 CNY . This corresponds to a dividend yield of about 0.18 %. For the coming 12 months, Betta Pharmaceuticals Co is expected to pay a dividend of 0.07 CNY.
What is the dividend yield of Betta Pharmaceuticals Co?
The current dividend yield of Betta Pharmaceuticals Co is 0.18 %.
When does Betta Pharmaceuticals Co pay dividends?
Betta Pharmaceuticals Co pays a quarterly dividend. This is distributed in the months of May, June, July, July.
How secure is the dividend of Betta Pharmaceuticals Co?
Betta Pharmaceuticals Co paid dividends every year for the past 10 years.
What is the dividend of Betta Pharmaceuticals Co?
For the upcoming 12 months, dividends amounting to 0.07 CNY are expected. This corresponds to a dividend yield of 0.18 %.
In which sector is Betta Pharmaceuticals Co located?
Betta Pharmaceuticals Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Betta Pharmaceuticals Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Betta Pharmaceuticals Co from 6/6/2024 amounting to 0.17 CNY, you needed to have the stock in your portfolio before the ex-date on 6/6/2024.
When did Betta Pharmaceuticals Co pay the last dividend?
The last dividend was paid out on 6/6/2024.
What was the dividend of Betta Pharmaceuticals Co in the year 2023?
In the year 2023, Betta Pharmaceuticals Co distributed 0.25 CNY as dividends.
In which currency does Betta Pharmaceuticals Co pay out the dividend?
The dividends of Betta Pharmaceuticals Co are distributed in CNY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Betta Pharmaceuticals Co
Our stock analysis for Betta Pharmaceuticals Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Betta Pharmaceuticals Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Betta Pharmaceuticals Co Revenue
- Betta Pharmaceuticals Co Net Income
- Betta Pharmaceuticals Co P/E
- Betta Pharmaceuticals Co P/S
- Betta Pharmaceuticals Co EBIT
- Betta Pharmaceuticals Co Dividend
- Betta Pharmaceuticals Co Stocks
- Betta Pharmaceuticals Co Market capitalization
- Betta Pharmaceuticals Co Debt
- Betta Pharmaceuticals Co Liabilities
- Betta Pharmaceuticals Co Equity
- Betta Pharmaceuticals Co AAQS
- Betta Pharmaceuticals Co Employees
- Betta Pharmaceuticals Co ROE
- Betta Pharmaceuticals Co ROA
- Betta Pharmaceuticals Co ROCE